| Fibrolamellar Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived25 of 25show fewer |
|---|
| → investigated in trials for | Nivolumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Fibrolamellar Carcinoma | 1 | Observed | clinicaltrials | graph → |